mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.03 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.03 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.03 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.03 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.03 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.094 |
0.03 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.03 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.093 |
0.04 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.04 |